From January 2006, all elderly people can be entitled to a federally subsidized prescription drug discount card. The cards will offer prescription drug discount card provided through private third party plans. They will grant discounts of 10 percent to 25 percent off the price of prescriptions. It is going to be competitive to card programs that are offered by pharmaceutical companies and drug producers. Pharmacy operators unwilling to attend the program take the risk of losing the customers. Their pharmacists will have to explain how the federal card works.
From January 2006, all elderly people can be entitled to a federally subsidized prescription drug discount card. The cards will offer prescription drug discount card provided through private third party plans. They will grant discounts of 10 percent to 25 percent off the price of prescriptions. It is going to be competitive to card programs that are offered by pharmaceutical companies and drug producers. Pharmacy operators unwilling to attend the program take the risk of losing the customers. Their pharmacists will have to explain how the federal card works.
The government will pay for the prescription card that were approved by The Medicare. That includes an annual $600 subsidy for low-income pensioners.
The project starts in 2006. The benefits for the participants of the project will be provided by PBMs and other third parties. Pharmacists must examine the claims and assure qualifications to receive the money.
Medicines retailers can sell 90-day supplies of maintenance prescription drugs, but may have to charge pensioners a higher co-pay.
PBMs will have the permission to offer seniors a possibility to order via mail. Thanks to it they will be able to steer them into their own mail subsidiaries. What’s more, next year Congress will consider adjustments to the law in order to avoid conflict-of-interest abuses.
Thanks to the use of e-prescribing, the Department of Health and Human Services can develop electronic transmission standards. It would reduce bureaucracy, however, the new drug benefit bill does not promote the use of e-prescribing.
Prescription dispensing volumes will probably increase considerably as utilization rises. However, profit margins can encounter further pressure. According to the law, pharmaceutical producers avoided calls by some lawmakers for direct purchases or controls of costs by the government.
